Zika Virus Purifi ed Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study Z001
Date
2016Author
Stephenson, Kathryn
Hale, Andrew
Ansel, Jessica
et al.
Metadata
Show full item recordAbstract
This is a phase 1 trial of one or more administrations of Zika Virus Purified Inactivated Vaccine (ZPIV). The trial will be conducted under a placebo controlled, double-blind, randomized allocation of study product. There are four groups in the study. Each group is testing a different vaccine schedule.